1. Home
  2. AIRG vs PMVP Comparison

AIRG vs PMVP Comparison

Compare AIRG & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$7.02

Market Cap

84.3M

Sector

Technology

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.11

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRG
PMVP
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.3M
76.8M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
AIRG
PMVP
Price
$7.02
$1.11
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$6.25
N/A
AVG Volume (30 Days)
96.1K
307.4K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
31.65
N/A
EPS
N/A
N/A
Revenue
$51,779,000.00
N/A
Revenue This Year
$10.31
N/A
Revenue Next Year
$20.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$0.96
52 Week High
$7.66
$1.88

Technical Indicators

Market Signals
Indicator
AIRG
PMVP
Relative Strength Index (RSI) 51.91 36.92
Support Level $6.52 $1.04
Resistance Level $7.52 $1.26
Average True Range (ATR) 0.40 0.06
MACD -0.06 -0.01
Stochastic Oscillator 32.27 27.78

Price Performance

Historical Comparison
AIRG
PMVP

About AIRG Airgain Inc.

Airgain Incs a provider of advance wireless connectivity solutions. It is focused on delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. It mission is to connect the world through integrated, and optimized wireless solutions. Companies' diverse product portfolio serves three primary markets: enterprise, automotive, and consumer. While historically recognized for high-performance radio frequency (RF) components, Airgain is increasingly delivering integrated, system-level connectivity solutions that combine hardware, software, and cloud management. The enterprise market demands reliable wireless access across diverse settings, including smart cities, campuses, stadiums, transportation hubs, utilities, buildings suburbs.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: